Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
STERIS plc
STE
NYSE·Healthcare·Medical - Specialties·Mkt cap $20.7B
$217.59
▲ +2.49%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$195.14 - $269.44
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 10.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Global sterilization facility network
- Comprehensive infection prevention portfolio
- Advanced medical equipment engineering
- Extensive healthcare industry experience
Bear Case
2 risks
- Average volatility.
- Premium valuation to Medical Devices peers
Growth
Stable outlook
Increasing healthcare infection control standards
Value
Premium valuation to Medical Devices peers
Momentum
Stable
-2.9% over 3m
Quality
Strong
Excellent business quality
Dividend
Modest
1.19% yield
Smart-money signal
Who's buying STE right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Aug 5, 2026
MAY 11, 2026
Reported EPS of $2.83 vs $2.86 consensus (-1.1% surprise). Revenue of $1.6B vs $1.6B expected (-0.4%).
EPS surprise · last 4Q
0 of 1 beats
Q2 26
-1.1%
Next: Aug 5, 2026
Revenue trend · last 8Q
—
—
—
+6%
+33%
+9%
+10%
+9%
Q4 24
Q1 24
Q2 24
Q3 24
Q4 25
Q1 25
Q2 25
Q3 25
$1.1B
$1.3B
$1.3B
$1.4B
$1.5B
$1.4B
$1.5B
$1.5B
Margins · last 8Q
Gross
43.8%
Operating
18.1%
Profit
12.9%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
$269.50
▲ +23.9% vs $217.59
Latest: Piper Sandler · $270.00 · May 21, 2026
2 analysts covering
vs Industry
How STE stacks vs Medical - Specialties
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related